Literature DB >> 21717456

Absence of common activating mutations of the epidermal growth factor receptor gene in thyroid cancers from American and Japanese patients.

Julio C Ricarte-Filho, Michiko Matsuse, Christopher Lau, Mabel Ryder, Eijun Nishihara, Ronald A Ghossein, Marc Ladanyi, Shunichi Yamashita, Norisato Mitsutake, James A Fagin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21717456      PMCID： PMC3276702          DOI： 10.1002/ijc.26267

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  13 in total

Review 1.  Update on epidermal growth factor receptor mutations in non-small cell lung cancer.

Authors:  Gregory J Riely; Katerina A Politi; Vincent A Miller; William Pao
Journal:  Clin Cancer Res       Date:  2006-12-15       Impact factor: 12.531

2.  Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.

Authors:  Constantine S Mitsiades; Vassiliki Kotoula; Vassiliki Poulaki; Elias Sozopoulos; Joseph Negri; Elpida Charalambous; Galinos Fanourakis; Gerassimos Voutsinas; Sophia Tseleni-Balafouta; Nicholas Mitsiades
Journal:  J Clin Endocrinol Metab       Date:  2006-07-05       Impact factor: 5.958

3.  Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer.

Authors:  Bradley A Schiff; Andrea B McMurphy; Samar A Jasser; Maher N Younes; Dao Doan; Orhan G Yigitbasi; Seungwon Kim; Ge Zhou; Mahitosh Mandal; Benjamin N Bekele; F Christopher Holsinger; Steven I Sherman; Sai-Ching Yeung; Adel K El-Naggar; Jeffrey N Myers
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

4.  Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

Authors:  Hisayuki Shigematsu; Li Lin; Takao Takahashi; Masaharu Nomura; Makoto Suzuki; Ignacio I Wistuba; Kwun M Fong; Huei Lee; Shinichi Toyooka; Nobuyoshi Shimizu; Takehiko Fujisawa; Ziding Feng; Jack A Roth; Joachim Herz; John D Minna; Adi F Gazdar
Journal:  J Natl Cancer Inst       Date:  2005-03-02       Impact factor: 13.506

5.  A phase II study of gefitinib in patients with advanced thyroid cancer.

Authors:  Nathan A Pennell; Gilbert H Daniels; Robert I Haddad; Douglas S Ross; Tracey Evans; Lori J Wirth; Panos H Fidias; Jennifer S Temel; Sarada Gurubhagavatula; Rebecca Suk Heist; John R Clark; Thomas J Lynch
Journal:  Thyroid       Date:  2008-03       Impact factor: 6.568

6.  Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.

Authors:  Hisayuki Shigematsu; Takao Takahashi; Masaharu Nomura; Kuntal Majmudar; Makoto Suzuki; Huei Lee; Ignacio I Wistuba; Kwun M Fong; Shinichi Toyooka; Nobuyoshi Shimizu; Takehiko Fujisawa; John D Minna; Adi F Gazdar
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

7.  Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.

Authors:  Zhi Liu; Peng Hou; Meiju Ji; Haixia Guan; Kimberly Studeman; Kirk Jensen; Vasily Vasko; Adel K El-Naggar; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

8.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.

Authors:  Simon A Forbes; Nidhi Bindal; Sally Bamford; Charlotte Cole; Chai Yin Kok; David Beare; Mingming Jia; Rebecca Shepherd; Kenric Leung; Andrew Menzies; Jon W Teague; Peter J Campbell; Michael R Stratton; P Andrew Futreal
Journal:  Nucleic Acids Res       Date:  2010-10-15       Impact factor: 16.971

9.  Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.

Authors:  Jeffrey C Lee; Igor Vivanco; Rameen Beroukhim; Julie H Y Huang; Whei L Feng; Ralph M DeBiasi; Koji Yoshimoto; Jennifer C King; Phioanh Nghiemphu; Yuki Yuza; Qing Xu; Heidi Greulich; Roman K Thomas; J Guillermo Paez; Timothy C Peck; David J Linhart; Karen A Glatt; Gad Getz; Robert Onofrio; Liuda Ziaugra; Ross L Levine; Stacey Gabriel; Tomohiro Kawaguchi; Keith O'Neill; Haumith Khan; Linda M Liau; Stanley F Nelson; P Nagesh Rao; Paul Mischel; Russell O Pieper; Tim Cloughesy; Daniel J Leahy; William R Sellers; Charles L Sawyers; Matthew Meyerson; Ingo K Mellinghoff
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

10.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962
View more
  1 in total

1.  Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.

Authors:  Kevin E Fisher; Jigna C Jani; Sarah B Fisher; Cora Foulks; Charles E Hill; Collin J Weber; Cynthia Cohen; Jyotirmay Sharma
Journal:  J Surg Res       Date:  2013-05-23       Impact factor: 2.192
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.